sacituzumab
gilead sciences
['sacitu, govi', 'bcsm', 'sacituzumab', 'breast']
sacituzumab govitecan-hziy demonstrates promising efficacy in her2-low/her2-0 metastatic breast cancer #bcsm #esmo2022 
Healthcare publisher of oncology focused articles, videos, panel discussions, and much more that run the gamut of oncology care and management.